Immunotherapy plus chemo shows promise for rare cervical cancer
NCT ID NCT07336147
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether adding the immunotherapy drug dostarlimab to standard chemotherapy and radiation can help women with a rare and aggressive type of cervical cancer called small cell neuroendocrine carcinoma. About 45 women with early to advanced stages of the disease will receive the combination treatment. The goal is to see if this approach improves how long women live without their cancer getting worse, compared to past results with standard treatment alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dostarlimab (an immunotherapy drug) combined with cisplatin and etoposide (chemotherapy) and radiotherapy
- What this could lead to
- If successful, this could offer a more effective treatment option for a rare and aggressive cervical cancer, potentially improving survival rates.
- What could go wrong
- This is a small Phase 2 trial with only 45 participants, so results may not apply to all patients. The combination therapy may cause significant side effects, and the improvement in survival is not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital, Linkou Branch
RECRUITINGTaoyuan, Taiwan, 333, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One pill, many questions: could emergency contraception briefly alter blood vessel health?
- Can couples counseling lift depression in women?
- Could a daily probiotic help you feel fuller and eat less?
- Muscle mystery: why strength training may work differently in men and women
- New scan could spot breast cancer markers without a needle
- New scan could replace biopsies for breast cancer monitoring